Description

6,7,8,9-Tetrahydro-2-(Hexahydro-1H-Azepin-1-Yl)-3-[(2-Oxooxazolidin-3-Yl)Iminomethyl]-4H-Pyrido[1,2-A]Pyrimidin-4-One is a complex heterocyclic organic compound that serves as a sophisticated building block and key intermediate in advanced chemical synthesis. Its intricate molecular architecture, featuring fused pyrimidine and oxazolidinone motifs, makes it a valuable precursor for developing novel pharmacologically active agents. This high-purity intermediate is primarily targeted at research institutions and pharmaceutical companies engaged in the discovery and development of new therapeutic compounds, particularly within medicinal chemistry programs.

Application

• Pharmaceutical Intermediate: A critical building block in the synthesis of novel drug candidates, particularly for central nervous system (CNS) and antimicrobial targets.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes in drug discovery.
• Organic Synthesis Reference Standard: Serves as a high-purity reference material for analytical method development and validation in QC laboratories.
• Chemical Biology Probe Development: Utilized in the creation of molecular probes to study specific biological pathways and protein interactions.
• Advanced Material Synthesis: Potential precursor for specialized polymers or ligands with unique electronic or binding properties.
• Contract Research & Manufacturing (CRMO): Supplied to organizations providing custom synthesis and process development services.

Basic Information

Product Name	6,7,8,9-Tetrahydro-2-(Hexahydro-1H-Azepin-1-Yl)-3-[(2-Oxooxazolidin-3-Yl)Iminomethyl]-4H-Pyrido[1,2-A]Pyrimidin-4-One
CAS No.	67466-15-3
Molecular Formula	C18H25N5O3
Molecular Weight	359.43 g/mol
Synonyms	4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro-2-(hexahydro-1H-azepin-1-yl)-3-[(2-oxooxazolidin-3-yl)iminomethyl]-; 3-[(2-Oxooxazolidin-3-yl)iminomethyl]-2-(hexahydro-1H-azepin-1-yl)-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one; 67466-15-3; UNII-9F6J2V1Q0F; 9F6J2V1Q0F; SCHEMBL218157; DTXSID60672908; BDBM50388875
EINECS	Contact for details

Quality Control

Our 6,7,8,9-Tetrahydro-2-(Hexahydro-1H-Azepin-1-Yl)-3-[(2-Oxooxazolidin-3-Yl)Iminomethyl]-4H-Pyrido[1,2-A]Pyrimidin-4-One is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity suitable for research and development. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. Our quality protocols are designed to meet the stringent requirements of pharmaceutical intermediate applications, with analytical methods validated for accuracy and precision.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at a controlled room temperature (typically 15-25°C). For long-term storage, consider storing under an inert atmosphere to maintain stability. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.